*Some Market data delayed by 15 mins.

Illumina Inc

Symbol: ILMN (NASDAQ)
94.55 ▲ (2.92%) 2.680

Company Description:
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Key Stats
  • Today's Open: $91.64
  • Today's High: $95.371
  • Today's Low: $91.145
  • Today's Volume: 2.13M
  • Yesterday Close: $91.87
  • Yesterday High: $92.5
  • Yesterday Low: $90.62
  • Yesterday Volume: 1.46M
  • Last Min Volume: 1
  • Last Min High: $94.55
  • Last Min Low: $94.55
  • Last Min VWAP: $94.55
Company Profile
  • Name: Illumina Inc
  • Website: https://www.illumina.com
  • Listed Date: 2000-07-28
  • Location: SAN DIEGO, CA
  • Market Status: Active
  • CIK Number: 0001110803
  • SIC Code: 3826
  • SIC description: LABORATORY ANALYTICAL INSTRUMENTS
  • Market Cap: $14.12B
  • Round Lot: 100
  • Outstanding Shares: 153.70M
  • Asset Type: CS
RECENT FILINGS FOR ILMN
Filing Date Filing Type Format
2025-09-09 4 View
2025-08-13 SCHEDULE 13G/A View
2025-08-01 10-Q View
2025-07-31 8-K View
2025-07-08 4 View
2025-07-02 4 View
2025-06-23 8-K View
2025-05-23 4 View
2025-05-23 4 View
2025-05-23 4 View
2025-05-23 4 View
2025-05-23 4 View
2025-05-23 4 View
2025-05-23 4 View
2025-05-23 4 View
2025-05-23 4 View
2025-05-23 4 View
2025-05-23 8-K View
2025-05-20 4 View
2025-05-20 4 View
Latest News on ILMN

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.